Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Chelstrom

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 1, 1987
Effect of multiple heatings on the blood flow in RIF-1 tumours, skin and muscle of C3H miceC W Song, M S Patten, L M Chelstrom, et al.
Leukemia & Lymphoma|June 5, 1998
Combined therapeutic efficacy of the thymidylate synthase inhibitor ZD1694 (Tomudex) and the immunotoxin B43(anti-CD19)-PAP in a SCID mouse model of human B-lineage acute lymphoblastic leukemiaO Ek, G H Reaman, D L Crankshaw, et al.
Blood|July 1, 1994
Childhood acute myeloid leukemia in mice with severe combined immunodeficiencyL M Chelstrom, R Gunther, J Simon, et al.
Leukemia & Lymphoma|April 1, 1993
Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxinF M Uckun, D E Myers, J D Irvin, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virusF M Uckun, L M Chelstrom, L Tuel-Ahlgren, et al.
Leukemia|February 1, 1993
In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiencyR Gunther, L M Chelstrom, D Finnegan, et al.
Blood|June 15, 1992
Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamideF M Uckun, L M Chelstrom, D Finnegan, et al.
Leukemia|February 1, 1993
Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamideB Jansen, J H Kersey, W B Jaszcz, et al.
Blood|December 1, 1995
In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cellsK G Waddick, D E Myers, R Gunther, et al.
Blood|August 1, 1994
Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiencyF M Uckun, J R Downing, L M Chelstrom, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 1, 1987
Effect of multiple heatings on the blood flow in RIF-1 tumours, skin and muscle of C3H miceC W Song, M S Patten, L M Chelstrom, et al.
Leukemia & Lymphoma|June 5, 1998
Combined therapeutic efficacy of the thymidylate synthase inhibitor ZD1694 (Tomudex) and the immunotoxin B43(anti-CD19)-PAP in a SCID mouse model of human B-lineage acute lymphoblastic leukemiaO Ek, G H Reaman, D L Crankshaw, et al.
Blood|July 1, 1994
Childhood acute myeloid leukemia in mice with severe combined immunodeficiencyL M Chelstrom, R Gunther, J Simon, et al.
Leukemia & Lymphoma|April 1, 1993
Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxinF M Uckun, D E Myers, J D Irvin, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virusF M Uckun, L M Chelstrom, L Tuel-Ahlgren, et al.
Leukemia|February 1, 1993
In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiencyR Gunther, L M Chelstrom, D Finnegan, et al.
Blood|June 15, 1992
Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamideF M Uckun, L M Chelstrom, D Finnegan, et al.
Leukemia|February 1, 1993
Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamideB Jansen, J H Kersey, W B Jaszcz, et al.
Blood|December 1, 1995
In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cellsK G Waddick, D E Myers, R Gunther, et al.
Blood|August 1, 1994
Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiencyF M Uckun, J R Downing, L M Chelstrom, et al.
Pageof 4